Journal Article

Magnetic susceptibility as a 1-year predictor of outcome in familial cerebral cavernous malformations: a pilot study

Meessen, Jennifer Marie Theresia Anna, Vasamì, Antonella, d’Orio, Piergiorgio, Siggillino, Silvia, Nicolis, Enrico Bjorn, Fusco, Massimo, Dejana, Elisabetta, Latini, Roberto, Contarino, Valeria Elisa, Gaudino, Chiara, Incerti, Irene, Conte, Giorgio, Pallini, Roberto, Lanfranconi, Silvia, Bianchi, Anna Maria, Bertani, Giulio Andrea, Scola, Elisa, D’Alessandris, Quintino Giorgio, Triulzi, Fabio Maria

2023

Overview

Objectives To test whether quantitative susceptibility mapping (QSM) of cerebral cavernous malformations (CCMs) assessed at baseline may predict the presence or absence of haemorrhagic signs at 1-year follow-up. Methods Familial CCM patients were enrolled in the longitudinal multicentre study Treat-CCM. The 3-T MRI scan allowed performing a semi-automatic segmentation of CCMs and computing the maximum susceptibility in each segmented CCM (QSMmax) at baseline. CCMs were classified as haemorrhagic and non-haemorrhagic at baseline and then subclassified according to the 1-year (t1) evolution. Between-group differences were tested, and the diagnostic accuracy of QSMmax in predicting the presence or absence of haemorrhagic signs in CCMs was calculated with ROC analyses. Results Thirty-three patients were included in the analysis, and a total of 1126 CCMs were segmented. QSMmax was higher in haemorrhagic CCMs than in non-haemorrhagic CCMs ( p < 0.001). In haemorrhagic CCMs at baseline, the accuracy of QSMmax in differentiating CCMs that were still haemorrhagic from CCMs that recovered from haemorrhage at t1 calculated as area under the curve (AUC) was 0.78 with sensitivity 62.69%, specificity 82.35%, positive predictive value (PPV) 93.3% and negative predictive value (NPV) 35.9% (QSMmax cut-off ≥ 1462.95 ppb). In non-haemorrhagic CCMs at baseline, AUC was 0.91 in differentiating CCMs that bled at t1 from stable CCMs with sensitivity 100%, specificity 81.9%, PPV 5.1%, and NPV 100% (QSMmax cut-off ≥ 776.29 ppb). Conclusions The QSMmax in CCMs at baseline showed high accuracy in predicting the presence or absence of haemorrhagic signs at 1-year follow-up. Further effort is required to test the role of QSM in follow-up assessment and therapeutic trials in multicentre CCM studies. Key Points • QSM in semi-automatically segmented CCM was feasible. • The maximum magnetic susceptibility in a single CCM at baseline may predict the presence or absence of haemorrhagic signs at 1-year follow-up. • Multicentric studies are needed to enforce the role of QSM in predicting the CCMs’ haemorrhagic evolution in patients affected by familial and sporadic forms.

• Publisher: Springer Berlin Heidelberg,Springer Nature B.V
• Subject: Accuracy / Clinical trials / Diagnostic Radiology / Evolution / Hemangioma, Cavernous, Central Nervous System - diagnostic imaging / Hemorrhage / Humans / Image processing / Image segmentation / Imaging / Internal Medicine / Interventional Radiology / Magnetic permeability / Magnetic Resonance / Magnetic Resonance Imaging / Magnetic susceptibility / Mathematical analysis / Medicine / Medicine & Public Health / Neuroradiology / Pilot Projects / Radiology / Sensitivity / Susceptibility / Ultrasound